TickerGuard
Buy Day today: Neutral (56) Mixed market breadth · no major macro event
AMGN

Amgen Inc

Healthcare · Drug Manufacturers - General

414.60$ +2.1% vs. previous close Closing price · As of: Sep 25, 2026

Statements

Cash Flow

All figures as a percentage of revenue in the same period.

Tick rows to compare them in a chart (up to 4)

Cash Flow AMGN
Line item 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
42.6% 41.9% 45.0% 48.9% 47.6% 39.2% 41.3% 35.6% 36.9% 30.0% 34.4% 27.1%
10.4% 9.7% 9.2% 8.6% 8.2% 9.4% 14.2% 13.1% 13.0% 14.4% 16.7% 14.1%
2.0% 1.5% 1.4% 1.4% 1.3% 1.3% 1.3% 1.3% 1.5% 1.5% 1.6% 1.3%
0.9% -3.2% 2.3% -2.9% 1.4% 0.9% -0.6% 13.0% 1.8% – – –
5.6% 3.3% 0.0% 34.6% 2.6% -3.1% -0.8% -4.6% -2.8% -1.7% 7.1% -5.4%
5.0% 3.0% 3.6% 2.9% 3.1% 2.6% 2.4% 3.4% 3.6% 3.9% 3.3% 5.1%
-28.7% -25.6% -37.7% -17.6% 60.4% 24.4% -21.2% 2.8% -23.0% -93.0% -3.1% -5.3%
9.2% 11.1% 13.0% 14.7% 14.8% 15.0% 14.8% 15.4% 15.9% 16.2% 14.5% 13.9%
-0.7% -8.6% -12.9% -13.8% -74.9% -33.0% -13.7% -19.2% -24.2% 0.0% -0.6% 0.0%
-5.6% 4.9% 15.6% 0.3% -4.7% -19.3% 9.7% 3.1% 25.2% 93.4% -10.8% -13.6%
-14.3% -14.4% -11.3% -28.9% -94.7% -67.5% -19.1% -31.8% -15.3% 74.7% -28.2% -29.6%
-0.4% 1.9% -3.9% 2.4% 13.2% -3.9% 0.9% 6.6% -1.4% 11.8% 3.1% -7.7%
37.6% 38.9% 41.4% 46.0% 44.5% 36.5% 38.9% 32.3% 33.4% 26.1% 31.1% 22.0%

Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?